By Professor Kathy Petoumenos

Journal articles

Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G; Dolan K, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/QAD.0b013e3283553719

Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033

Rajasuriar R; Gouillou M; Spelman T; Read T; Hoy JF; Law MG; Cameron P; Petoumenos K; Lewin S, 2011, 'Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the australian HIV observational database', PLoS One, 6, pp. e20713, http://dx.doi.org/10.1371/journal.pone.0020713

McManus H; Lim P; Nolan D; Bloch M; Kiertiburanakul S; Choi J; Mulhall BP; Petoumenos K; Zhou J; Law MG; Brew BJ; Wright E, 2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?', HIV Medicine, 12, pp. 610 - 619, http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x

Worm SW; Kamara DA; Reiss P; Kirk O; El-Sadr W; Fux C; Fontas E; Phillips A; D''arminio Monforte A; De Wit S; Petoumenos K; Friis-Moller N; Mercie P; Lundgren JD; Sabin C, 2011, 'Elevated triglycerides and risk of myocardial infarction in HIV-positive persons', AIDS, 25, pp. 1497 - 1504, http://dx.doi.org/10.1097/QAD.0b013e32834917c6

Bunupuradah T; Ananworanich J; Chetchotisakd P; Kantipong P; Jirajariyavej S; Sirivichayakul S; Munsakul W; Prasithsirikul W; Sungkanuparph S; Bowonwattanuwong C; Klinbuayaem V; Petoumenos K; Hirschel B; Bhakeecheep S; Ruxrungtham K, 2011, 'Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens', Antiviral Therapy, 16, pp. 1113 - 1121, http://dx.doi.org/10.3851/IMP1906

Van Bockel DJ; Ammaranond P; Petoumenos K; Mcmurchie M; Finlayson RJ; Middleton MG; Davenport ; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD, 2011, 'HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome', Journal of Immunology, 186, pp. 479 - 488, http://www.jimmunol.org/content/186/1/479

Petoumenos K; Worm SW, 2011, 'HIV infection, ageing and cardiovascular disease: Epidemiology and prevention', Sexual Health, 8, pp. 465 - 473, http://search.informit.com.au/documentSummary;dn=535450990470779;res=IELHEA

Bunupuradah T; Ananworanich J; Pancharoen C; Petoumenos K; Prasitsuebsai W; Wongngam W; Ubolyam S; Sriheara C; Lange J; Phanuphak P; Puthanakit T, 2011, 'Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression', Vaccine, 29, pp. 2962 - 2967, http://dx.doi.org/10.1016/j.vaccine.2011.01.114

Petoumenos K; Worm S; Reiss P; De Wit S; D''arminio monforte A; Sabin C; Friis-Moller N; Weber R; Mercie P; Pradier C; El-Sadr W; Kirk O; Lundgren JD; Law MG, 2011, 'Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D:A:D study', HIV Medicine, 12, pp. 412 - 421, http://dx.doi.org/10.1111/j.1468-1293.2010.00901.x

Achhra AC; Zhou J; Choi JY; Hoy J; Zhang F; Templeton DJ; Merati T; Woolley I; Petoumenos K; Amin J, 2011, 'The clinical significance of CD4 counts in asian and caucasian HIV-infected populations: Results from TAHOD and AHOD', Journal of the International Association of Physicians in AIDS Care, 10, pp. 160 - 170, http://dx.doi.org/10.1177/1545109711402213

Law MG; Woolley I; Templeton DJ; Roth N; Chuah J; Mulhall BP; Canavan P; Mcmanus H; Cooper DA; Petoumenos K, 2011, 'Trends in detectable viral load by calendar year in the Australian HIV observational database', Journal of the International AIDS Society, 14, pp. 10, http://dx.doi.org/10.1186/1758-2652-14-10

Marashi Pour S; Woolley I; Canavan P; Chuah J; Russell DB; Law MG; Petoumenos K, 2011, 'Triple Class Experience after Initiation of Combination Antiretroviral Treatment in Australia: Survival and Projections', Sexual Health, 8, pp. 295 - 303, http://search.informit.com.au/documentSummary;dn=359164449396949;res=IELHEA

Grebely J; Matthews GV; Petoumenos K; Dore GJ, 2010, 'Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection', Journal of Viral Hepatitis, 17, pp. 896, http://dx.doi.org/10.1111/j.1365-2893.2009.01256.x

Molano M; Tabrizi SN; Garland SM; Roberts JM; MacHalek DA; Phillips S; Chandler D; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Cornall AM; McCaffery K; Howard K; Farnsworth A; Fairley K; Prestage G; Carr A; Tong W; Law C; Acraman B; Crampton L; Feeney L; Fraissard E; Law M; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Varma R; Han A, 2010, 'CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker', Plos One, 11, pp. e0160673, http://dx.doi.org/10.1371/journal.pone.0160673

Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YF; Merati T; Zhang F; Lim P; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich AE; Law MG, 2010, 'Cancers in the Treat Asia HIV Observational Database (TAHOD): A retrospective analysis of risk factors', Journal of the International AIDS Society, 13, pp. 1 - 14, http://www.jiasociety.org/content/13/1/51

Winston A; Duncombe C; Li P; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA, 2010, 'Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study', Clinical Infectious Diseases, 50, pp. 920 - 929

Puls R; Srasuebkul P; Petoumenos K; Boesecke C; Duncombe CJ; Belloso WH; Molina J; Li L; Avihingsanon A; Gazzard B; Cooper DA; Emery S, 2010, 'Efavirenz versus boosted atazanavir or zidovudine and abacavir in antirectroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study', Clinical Infectious Diseases, Oct 1; 51, pp. 855 - 864

Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019

Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015

Carey DL; Amin J; Boyd MA; Petoumenos K; Emery S, 2010, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomised controlled trials', Journal of Antimicrobial Chemotherapy, 65, pp. 1878 - 1888

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; Van Beek I; Kaldor J; Dore GJ, 2009, 'TREATMENT OF RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTION DRUG USER COHORT: THE ATAHC STUDY', DRUG AND ALCOHOL REVIEW, 28, pp. A27 - A27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Puls R; Srasuebkul P; Petoumenos K, 2009, 'Anthropometric and metabolic outcomes in a 48-week randomized, open-label study of three different combination antiretroviral regimens as initial therapy for HIV infection', Antiviral Therapy, 14, pp. A8 - A9

Byakwaga H; Zhou J; Petoumenos K; Law MG; Boyd MA; Emery S; Cooper DA; Mallon PW, 2009, 'Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy', HIV Medicine, 10, pp. 143 - 151

Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, 25, pp. 569 - 576

Egger S; Petoumenos K; Kamarulzaman A; Hoy JF; Sungkanuparph S; Chuah J; Falster KA; Zhou J; Law MG, 2009, 'Long term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load and time: The Asia Pacific HIV Observational Database (APHOD)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50, pp. 513 - 520

Carey DL; Baker D; Petoumenos K; Chuah J; Rogers G; Watson J; Cooper DA; Emery S; Carr AD, 2009, 'Poly-L-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up', HIV Medicine, 10, pp. 163 - 172

Falster KA; Petoumenos K; Chuah J; Mijch AM; Mulhall BP; Kelly M; Cooper DA, 2009, 'Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression.', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50, pp. 307 - 313

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White PA; Ffrench R; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2009, 'Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort: the ATAHC Study', The Canadian Journal of Addiction, 1, pp. 33 - 33, http://dx.doi.org/10.1097/02024458-200912000-00072

Byakwaga H; Murray JM; Petoumenos K; Boyd MA; Emery S; Mallon PW; Cooper DA, 2008, 'Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression', Journal of the International AIDS Society, 11, http://dx.doi.org/10.1186/1758-2652-11-s1-p70

Sabin CA; Worm SW; Weber R; Reiss P; El-Sadr W; Dabis F; De Wit S; Law M; D'Arminio Monforte A; Friis-Møller N; Kirk O; Pradier C; Weller I; Phillips AN; Lundgren JD; Collins S; Rosseau F; Storfer SP; Sjøl A; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Hammer S; Neaton J, 2008, 'Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: A multi-cohort collaboration', Lancet, 371, pp. 1417 - 1426, http://dx.doi.org/10.1016/S0140-6736(08)60423-7

Monforte A; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law MG; de Witt S; Friis-Moller N; Phillips AN; Sabin C; Lundgren JD, 2008, 'HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.', AIDS, pp. 2143 - 2153

Petoumenos K; Fontas E; Worm SW; Weber R; De Wit S; Bruyand M; Sabin CA; Reiss P; El-Sadr W; Monforte AD; Friis-Møller N; Lundgren JD; Law MG, 2008, 'O314 Predicting the short-term risk of diabetes in HIV-infected patients in the D:A:D cohort: the D:A:D study group', Journal of the International AIDS Society, 11, pp. O30 - O30, http://dx.doi.org/10.1186/1758-2652-11-s1-o30

Falster KA; Gelgor L; Shaik A; Zablotska Manos I; Prestage G; Grierson J; Thorpe R; Pitts M; Anderson JS; Chuah J; Mulhall BP; Petoumenos K; Kelleher AD; Law MG, 2008, 'Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment', Sexual Health, 5, pp. 141 - 154

Carey DL; Baker D; Rogers G; Petoumenos K; Chuah J; Easey N; Mahon K; Cooper DA; Emery S; Carr AD, 2007, 'A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 46, pp. 581 - 589

Calmy A; Petoumenos K; Lewden C; Law MG; Bocquentin F; Hesse K; Cooper DA; Carr AD; Bonnet F, 2007, 'Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts', HIV Medicine, 8, pp. 171 - 180

Drake A; Loy CT; Brew BJ; Chen TP; Petoumenos K; Li P; Wright E, 2007, 'Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival', European Journal of Neurology, 14, pp. 418 - 423

Dore GJ; Hellard M; Matthews G; Haber PS; Shaw D; Yeung B; Petoumenos K; Van Beek IA; Mccaughan GW; Pan Y; Ffrench R; Rowlinson W; Lloyd AR; Kaldor JM, 2007, 'Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the Australian trial in acute hepatitis C (ATAHC)', Hepatology, 46, pp. 358A - 358A

Collins S; Mertenskoetter T; Loeliger E; Tressler R; Weller I; Friis-Møller N; Worm SW; Sabin CA; Sjøl A; Lundgren JD; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Weber R; Reisswafaamel-Sadr P; Kirk O; Dabis F; Law MG; Pradier C; De Wit S; Akerlund B; Calvo G; Monforte ADA; Ledergerber B; Phillips AN; De Wolf F; Zaheri S; Bronsveld W; Hillebrand-Haverkort ME; Prins JM; Bos JC; Schattenkerk JKME; Geerlings SE; Godfried MH; Lange JMA; Van Leth FC; Lowe SH; Van Der Meer JTM; Nellen FJB; Pogány K; Van Der Poll T; Reiss P; Ruys TA; Sankatsing SU; Steingrover R; Van Twillert G; Van Der Valk M; Van Vonderen MGA; Vrouenraets SME; Van Vugt MV; Wit FWMN; Van Eeden A; Ten Veen JH; Van Dam PS; Roos JC; Brinkman K; Frissen PHJ; Weigel HM; Mulder JW; Van Gorp ECM; Meenhorst PL; Mairuhu ATA; Veenstra J; Danner SA; Van Agtmael MA; Claessen FAP; Perenboom RM; Rijkeboer A; Richter C; Van Der Berg J; Van Leusen R; Vriesendorp R; Jeurissen FJF; Kauffmann RH; Koger ELW; Bravenboer B; Ten Napel CHH; Kootstra GJ; Sprenger HG; Miesen WMAJ; Doedens R; Scholvinck EH; Ten Kate RW; Van Houte DPF; Polee M; Kroon FP; Van Den Broek PJ; Van Dissel JT; Schippers EF; Schreij G; Van De Geest S, 2006, 'Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study', Archives of Internal Medicine, 166, pp. 1632 - 1641, http://dx.doi.org/10.1001/archinte.166.15.1632

Petoumenos K; Law MG, 2006, 'Risk factors and causes of death in the Australian HIV Observational Database. Sex Health', Sexual Health, 3, pp. 103 - 112

Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 42, pp. 192 - 202

Law MG; Friis-Moller N; El-Sadr W; Weber RO; Reiss P; Monforte A; Thiebaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Kirk O; Sabin C; Phillips AN; Lundgren JD, 2006, 'The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D : A : D Study', HIV Medicine, 7, pp. 218 - 230

Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, 6, pp. 155 - 163

Zhou J; Kumarasamy N, 2005, 'Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD)', HIV Medicine, 6, pp. 216 - 223

Monforte AD; Sabin CA; Phillips AN; Reiss P; Weber R; Kirk O; El-Sadr W; De Wit S; Mateu S; Petoumenos K; Dabis F; Pradier C; Morfeldt FL; Lundgren JD; Friis-Moller N; Collins S; Loeliger E; Tressler R; Weller I; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Zaheri S; Lavignolle V; Sundström A; Poll B; Fontas E; Torres F; Kjær J, 2004, 'Cardio- and cerebrovascular events in HIV-infected persons', AIDS, 18, pp. 1811 - 1817, http://dx.doi.org/10.1097/00002030-200409030-00010

Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6

Fontas E; van Leth F; Sabin C; Friis-Moller N; Rickenbach M; Monforte A; Kirk O; Dupon M; Morfeldt L; Mateu S; Petoumenos K; El-Sadr W; De Wit S; Lundgren JD; Pradier C; Reiss P, 2004, 'Lipid profiles in HIV-infected patients receiving combinationantiretroviral therapy: Are different antiretroviral drugs associatedwith different lipid profiles?', Journal of Infectious Diseases, 189, pp. 1056 - 1074

Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD; Bartsch G; Dabis F; Houyez F; Loeliger E; Tressler R; Weller I; Sjøl A; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Meester R; Lavignolle V; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Hammer S; Neaton J; de Wolf F; van der Ven E; Zaheri S; Van Valkengoed I; Bronsveld W; Weigel H; Brinkman K; Frissen P; ten Veen J; Hillebrand M; van Dam P; Schieveld S; Mulder J; van Gorp E; Meenhorst P; van Eeden A; Danner S; Claessen F; Perenboom R; Eeftinck Schattenkerk JK; Godfried M; Lange J; Lowe S; van der Meer J; Nellen F; Pogany K; van der Poll T; Prins J; Ruys T; van der Valk M; Wit F; Richter C; van Leusen R; Vriesendorp R; Jeurissen F; Kauffmann R; Koger E; Bravenboer B; ten Napel C; Sprenger HG; Law G; ten Kate RW; Leemhuis M; Kroon F; Schippers E; Schrey G; van der Geest S; Verbon A; Koopmans P; Keuter M; Telgt D; van der Ven A; van der Ende M; Gyssens I; de Marie S; Juttmann J; van der Heul C; Schneider M; Borleffs J; Hoepelman I; Jaspers C; Matute A; Schurink C, 2003, 'Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group', New England Journal of Medicine, 349, pp. 1993 - 2003, http://dx.doi.org/10.1056/NEJMoa030218

Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, 4, pp. 241 - 249

Back to profile page